NasdaqGS - Nasdaq Real Time Price USD

Acumen Pharmaceuticals, Inc. (ABOS)

Compare
1.8500 +0.0500 (+2.78%)
At close: December 20 at 4:00:02 PM EST
1.9000 +0.05 (+2.70%)
After hours: December 20 at 7:32:02 PM EST

Valuation Measures

Annual
Monthly
Currency in USD
Download
Current9/30/20246/30/20243/31/202412/31/20239/30/2023
Market Cap 110.55M 149.00M 145.39M 243.32M 222.38M 240.15M
Enterprise Value -61.33M -83.26M -79.15M 28.29M 6.94M 95.30M
Trailing P/E 4.40 -- -- -- -- --
Forward P/E -- -- -- -- -- --
PEG Ratio (5yr expected) -- -- -- -- -- --
Price/Sales -- -- -- -- -- --
Price/Book 0.51 0.61 0.55 0.91 0.79 1.42
Enterprise Value/Revenue -- -- -- -- -- --
Enterprise Value/EBITDA -0.60 -- -- -- -0.76 -5.96
9/30/2023 - 7/1/2021

Upgrade to begin using 40 years of earnings data and get so much more.

Build financial models with decades of earnings stats, ratios, and valuation data — all exportable — to power your trade ideas.

Upgrade

Financial Highlights

Fiscal Year

Fiscal Year Ends 12/31/2023
Most Recent Quarter (mrq) 9/30/2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm) 0.00%

Management Effectiveness

Return on Assets (ttm) -20.99%
Return on Equity (ttm) -32.83%

Income Statement

Revenue (ttm) --
Revenue Per Share (ttm) --
Quarterly Revenue Growth (yoy) --
Gross Profit (ttm) --
EBITDA -92.84M
Net Income Avi to Common (ttm) -81.67M
Diluted EPS (ttm) -1.3800
Quarterly Earnings Growth (yoy) --

Balance Sheet

Total Cash (mrq) 200.34M
Total Cash Per Share (mrq) 3.34
Total Debt (mrq) 29.99M
Total Debt/Equity (mrq) 13.81%
Current Ratio (mrq) 10.43
Book Value Per Share (mrq) 3.62

Cash Flow Statement

Operating Cash Flow (ttm) -67.31M
Levered Free Cash Flow (ttm) -41.69M

Trading Information

Stock Price History

Beta (5Y Monthly) 0.04
52 Week Range 3 -50.00%
S&P 500 52-Week Change 3 24.21%
52 Week High 3 5.0900
52 Week Low 3 1.7150
50-Day Moving Average 3 2.4877
200-Day Moving Average 3 2.8992

Share Statistics

Avg Vol (3 month) 3 239.73k
Avg Vol (10 day) 3 416.19k
Shares Outstanding 5 60.08M
Implied Shares Outstanding 6 60.08M
Float 8 32.42M
% Held by Insiders 1 11.24%
% Held by Institutions 1 78.46%
Shares Short (11/29/2024) 4 1.39M
Short Ratio (11/29/2024) 4 6.61
Short % of Float (11/29/2024) 4 3.10%
Short % of Shares Outstanding (11/29/2024) 4 2.31%
Shares Short (prior month 10/31/2024) 4 1.45M

Dividends & Splits

Forward Annual Dividend Rate 4 --
Forward Annual Dividend Yield 4 --
Trailing Annual Dividend Rate 3 0.00
Trailing Annual Dividend Yield 3 0.00%
5 Year Average Dividend Yield 4 --
Payout Ratio 4 0.00%
Dividend Date 3 --
Ex-Dividend Date 4 --
Last Split Factor 2 --
Last Split Date 3 --

Footnotes

  • 1 Data provided by Refinitiv.
  • 2 Data provided by EDGAR Online.
  • 3 Data derived from multiple sources or calculated by Yahoo Finance.
  • 4 Data provided by Morningstar, Inc.
  • 5 Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.
  • 6 Implied Shares Outstanding of common equity, assuming the conversion of all convertible subsidiary equity into common.
  • 7 EBITDA is calculated by S&P Global Market Intelligence using methodology that may differ from that used by a company in its reporting.
  • 8 A company's float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which may not be publicly traded.

Abbreviation Guide

  • mrq = Most Recent Quarter
  • ttm = Trailing Twelve Months
  • yoy = Year Over Year
  • lfy = Last Fiscal Year
  • fye = Fiscal Year Ending

Related Tickers